What the US Food and Drug Administration has cleared, approved and recalled on this topic, and the side effects people report.
Each number has its full source under its own list below.
2 recalls (since 1 Jan 2023). Recalls of medicines for this topic, newest first.
Reason: Subpotent Drug and Failed Impurities/Degradation Specifications
Reason: Subpotent Drug and Failed Impurities/Degradation Specifications
Source: openFDA, Drug recall enforcement reports, since 1 Jan 2023. Retrieved 12 Nov 2026.
3 recalls (since 1 Jan 2023). Recalls of medical devices for this topic, newest first.
Reason: Product testing did not meet expected stability criteria.
Reason: BD has received additional complaints of intermittent false resistance results for PZA during susceptibility testing of Mycobacterium tuberculosis isolates.
Reason: May intermittently produce falsely resistant results for pyrazinamide (PZA) during susceptibility testing of Mycobacterium tuberculosis isolates.
Source: openFDA, Medical device recalls, since 1 Jan 2023. Retrieved 12 Nov 2026.
5,023 side effect reports (reports received since 1 Jan 2023). The reactions named most often in reports about medicines used for this topic.
Anyone can send a report. A report does not prove that the medicine caused the reaction, and the counts do not show how often it happens.
Source: openFDA, FDA Adverse Event Reporting System (FAERS), reports by reaction, reports received since 1 Jan 2023. Retrieved 12 Nov 2026.
Countries side by side on public measures for this topic.
Worldwide · 2024–2034
View report Public HealthWorldwide · 2024–2034
View report Public HealthWorldwide · 2024–2034
View report Public HealthWorldwide · 2024–2034
View report Public HealthWorldwide · 2024–2034
View report Public HealthWorldwide · 2024–2034
View reportAcuitas market sizes and forecasts are only in our full reports. How we use public data.